共 277 条
[1]
Aas T(1996)Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients Nat Med 2 811-814
[2]
Borresen AL(1995)p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts Proc Natl Acad Sci USA 92 8493-8497
[3]
Geisler S(1993)An intergroup phase III randomized study of doxorubicin and dacarbacine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas J Clin Oncol 11 1276-1285
[4]
Smith-Sorensen B(1997)Adjuvant therapy of sarcomas of soft tissue Semin Oncol 24 556-560
[5]
Johnson H(1995)Expression of human all-trans-retinoic acid receptor beta and its ligand-binding domain in Biochem J 308 353-359
[6]
Varhaug JE(1995)Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy Nat Med 1 1029-1034
[7]
Akslen LA(1990)Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas Cancer 66 862-867
[8]
Lonning PE(1995)γ-Radiation-induced apoptosis in human colorectal adenoma and carcinoma cell lines can occur in the absence of wild-type p53 Oncogene 10 2391-2396
[9]
Agarwal ML(1997)Re: isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-γ and melphalan for non-resectable extremity soft tissue sarcomas: a multicenter trial J Clin Oncol 15 2174-2175
[10]
Agarwal A(1995)Growth factor modulation of p53-mediated growth arrest versus apoptosis Gene Dev 9 600-611